As pipeline competition intensifies and lifecycle timelines shorten, we are seeing pharmaceutical forecasting teams being asked to do more, with less time and greater uncertainty. From managing loss of exclusivity (LoE) to navigating saturated therapeutic areas, forecasters now play a central role in guiding business-critical decisions.
Our exclusive guide breaks down how teams can stay ahead of market shifts and deliver sharper, more strategic forecasts – across regions, asset classes, and development stages.
Download the full report to gain:
- A clear view of today’s pipeline dynamics and what rising asset saturation means for forecasting
- Approaches to model LoE and biosimilar impact with greater precision
- Regional and cross-portfolio strategies to support smarter planning under pressure
- Actionable insights to help your team drive agility, accuracy, and strategic value
